COVID - 19 Vaccination Update - Day 462 - Prevention is better than cure

Spread the Message

Read Time:1 Minute, 39 Second

Posted On: 22 APR 2022 8:10 PM by PIB Delhi

India’s COVID-19 vaccination coverage has crossed 187.44 Crore (1,87,44,58,383) today. More than 17 lakh (17,01,248) Vaccine Doses have been administered till 7 pm today. The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight.

The cumulative coverage of vaccine doses, segregated based on population priority groups, is as follows:

Cumulative Vaccine Dose Coverage
HCWs	1^st Dose	10404661
	2^nd Dose	10011387
	Precaution Dose	4676148
FLWs	1^st Dose	18414819
	2^nd Dose	17530930
	Precaution Dose	7299702
Age Group 12-14 years	1^st Dose	26146536
	2^nd Dose	2297896
Age Group 15-18 years	1^st Dose	58090624
	2^nd Dose	41160002
Age Group 18-44 years	1^st Dose	555443409
	2^nd Dose	474948612
	Precaution Dose	65064
Age Group 45-59 years	1^st Dose	202877492
	2^nd Dose	187261830
	Precaution Dose	243316
Over 60 years	1^st Dose	126834515
	2^nd Dose	116655220
	Precaution Dose	14096220
Cumulative 1^st dose administered		998212056
Cumulative 2^nd dose administered		849865877
Precaution Dose		26380450
Total		1874458383

Today’s achievement in the vaccination exercise, segregated by population priority groups, is as follows:

Date: 22^nd April, 2022 (462^nd Day)
HCWs	1^st Dose	46
	2^nd Dose	538
	Precaution Dose	14176
FLWs	1^st Dose	90
	2^nd Dose	801
	Precaution Dose	30463
Age Group 12-14 years	1^st Dose	345853
	2^nd Dose	504848
Age Group 15-18 years	1^st Dose	39602
	2^nd Dose	124960
Age Group 18-44 years	1^st Dose	28700
	2^nd Dose	338096
	Precaution Dose	6637
Age Group 45-59 years	1^st Dose	3756
	2^nd Dose	69405
	Precaution Dose	28999
Over 60 years	1^st Dose	2842
	2^nd Dose	45195
	Precaution Dose	116241
Cumulative 1^st dose administered		420889
Cumulative 2^nd dose administered		1083843
Precaution Dose		196516
Total		1701248

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level.